RXRX

Recursion Pharmaceuticals (RXRX) Earnings

Review Recursion Pharmaceuticals (RXRX) earnings with server-rendered company data, supporting context and links to related investor research.

Annual EPS
-1.44
Trailing EPS
-1.04
Annual revenue
$74.26M
Trailing revenue
$53.94M
Next earnings date
2026-08-05

Recursion Pharmaceuticals (RXRX) Earnings research

The RXRX earnings page organizes the available earnings-per-share and revenue context for Recursion Pharmaceuticals. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.

Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.